Author
Listed:
- Xiao Gao
(East China Normal University
The Second Military Medical University
East China Normal University)
- Qingwei Wang
(The Ohio State University)
- Ying Wang
(Hangzhou Normal University)
- Jiang Liu
(Hangzhou Normal University)
- Shuang Liu
(Guangdong Second Provincial General Hospital)
- Jian Liu
(National Institute of Environmental Health Sciences (NIEHS))
- Xingli Zhou
(East China Normal University)
- Li Zhou
(East China Normal University)
- Hui Chen
(East China Normal University)
- Linian Pan
(East China Normal University)
- Jiwei Chen
(East China Normal University)
- Da Wang
(East China Normal University
The Second Military Medical University)
- Qing Zhang
(Guangdong Second Provincial General Hospital)
- Shihui Shen
(East China Normal University)
- Yu Xiao
(East China Normal University)
- Zhipeng Wu
(East China Normal University
The Second Military Medical University)
- Yiyun Cheng
(East China Normal University)
- Geng Chen
(East China Normal University)
- Syeda Kubra
(East China Normal University)
- Jun Qin
(Institute of Lifeomics)
- Lan Huang
(University of California)
- Pei Zhang
(The Second Chengdu Municipal Hospital)
- Chuangui Wang
(Shanghai Jiao Tong University School of Medicine)
- Robb E. Moses
(Baylor College of Medicine)
- David M. Lonard
(Baylor College of Medicine)
- Bert W. O’ Malley
(Baylor College of Medicine)
- Fuad Fares
(University of Haifa)
- Bianhong Zhang
(East China Normal University)
- Xiaotao Li
(East China Normal University
Baylor College of Medicine)
- Lei Li
(East China Normal University)
- Jianru Xiao
(East China Normal University
The Second Military Medical University)
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Suggested Citation
Xiao Gao & Qingwei Wang & Ying Wang & Jiang Liu & Shuang Liu & Jian Liu & Xingli Zhou & Li Zhou & Hui Chen & Linian Pan & Jiwei Chen & Da Wang & Qing Zhang & Shihui Shen & Yu Xiao & Zhipeng Wu & Yiyun, 2020.
"Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells,"
Nature Communications, Nature, vol. 11(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18767-0
DOI: 10.1038/s41467-020-18767-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18767-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.